Shimamura Lab retweeted
Registration is now open for the #GreatLakesChapter of @ASPET 2023 Annual Meeting at @UofIllinois Chicago on June 1st, 2023. The undergraduate, graduate student, and postdoctoral poster sessions are open to all topics in pharmacology. Register here: aspet.org/aspet/membership-c…

ALT The Great Lakes Chapter of the American Society for Pharmacology and Experimental Therapeutics is having their 2023 Annual meeting on June 1st, 2023 at the University of Illinois--Chicago. The meeting is "Frontiers in Cancer Biology and Therapeutics." The Keynote Speaker is Andrew Souers, PhD from Abbvie. Main symposium speakers include Jaehyuk Choi MD, PhD of Northwestern University, VK Gadi MD, PhD of the University of Illinois Chicago, and Charlotte Kuperwasser PhD of Tufts University. There is also a young investigator symposium, Lunch and Learn, and Poster sessions for undergraduate, graduate, and postdoctoral researchers with awards.
Shimamura Lab retweeted
Moscat @SBPdiscovery & colleagues discuss the dual roles of the atypical PKCs in cancer.
cell.com/cancer-cell/fulltex…
Shimamura Lab retweeted
Mayor Lori Lightfoot To Seek Total Ban On Flavored E-Cigarettes In Chicago cbsloc.al/2UY1NaZ#.XX_F76iz1… Obviously, we agree. Well done @ChicagosMayor
Great job presenting our data at #WCLC2019 from our lab, Jeff! Got great feedback. @UICancerCenter
1
Shimamura Lab retweeted
A new standard for EGFR-mutant NSCLC? nature.com/articles/s41571-0… #LCSM
Shimamura Lab retweeted
In a analysis of pts from the FLAURA trial, osimertinib & the comparator treatment both provided longer PFS in plasma ctDNA EGFRm negative (23.5 and 15.0 months,) vs positive pats (15.2 and 9.7 months), potentially reflecting tumour burden: clincancerres.aacrjournals.o… #LCSM #camoldx







